Cleared Traditional

Agilis HisPro Steerable Catheter With Electrodes (K200721) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200721 · Abbott (St. Jude Medical) · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
76d
Days
Class 2
Risk

K200721 is an FDA 510(k) clearance for the Agilis HisPro Steerable Catheter With Electrodes. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Abbott (St. Jude Medical) (Sylmar, US). The FDA issued a Cleared decision on June 3, 2020 after a review of 76 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott (St. Jude Medical) devices

Submission Details

510(k) Number K200721 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 19, 2020
Decision Date June 03, 2020
Days to Decision 76 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 125d · This submission: 76d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 316
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K200721.
BOBBY Balloon Guide Catheter
K193607 · MicroVention, Inc. · Jul 2020
Twin-Pass Dual Access Catheter
K193119 · Vascular Solutions, LLC · Jun 2020
Benchmark BMX96 Access System
K201271 · Penumbra, Inc. · Jun 2020
Support Catheter
K200317 · Qxmedical, LLC · May 2020
XO Cross Support Catheter
K193420 · Transit Scientific · May 2020
Q3 Distal Access Catheter, Q4 Distal Access Catheter, Q5 Distal Access Catheter, Q6Distal Access Catheter
K192558 · Mivi Neurovascular · Apr 2020